Intervacc is trading 5.32% down at a live price of β¬0.06; no specific cause has been established.
- No company announcement for October 7β9 was found; Intervaccβs announcement listing shows its latest item dated September 15.
- Biotech weakness is supporting context, but available evidence does not establish that sector or global conditions directly explain this move.